Top 32 U.S. Pharmaceutical Products Stocks

Assets	Market Cap	Buy And Hold Score	P/E	P/BV	Dividend yield	Average DY 5 years	Net Profit Margins	Sector	ROE	Current Price	Graham's Fair Value	Graham Upside	Profit	Revenue	Revenue Growth 5 years	Profit Growth 5 years	Cash	Return 30d	Return 12m	Net Worth
#15 LLY Eli Lilly and Compay	1.02 T	70	38.31		0.56%	1.24%	33.53%	Health	-	$1,146.64	$6.36	-99.45%	7.10 B	22.97 B	22.98%	36.77%	8.95 B	-2.33%	56.56%	55.00 M
#187 GSK GlaxoSmithKline PLC	100.35 B	70	15.52	4.38	3.51%	7.52%	14.54%	Health	28.24%	$50.00	$28.75	-42.50%	580.00 M	11.21 B	3.75%	2.87%	4.14 B	-4.67%	29.14%	22.90 B
#294 SNY Sanofi	61.15 B	90	4.14	0.76	4.00%	4.62%	14.25%	Health	18.43%	$44.21	$118.00	166.89%	2.25 B	25.47 B	18.60%	15.33%	7.32 B	1.68%	-1.17%	80.15 B
#399 ONC BeiGene, Ltd.	41.72 B	40	63.62	8.06	0.00%	0.00%	10.70%	Health	12.67%	$358.72	$77.98	-78.26%	237.01 M	1.71 B	39.12%	-	5.10 B	3.61%	-	5.17 B

All U.S. Stocks of companies pharmaceutical products industry